Angelina Jolie has surprisingly faced a wave of online abuse. Her recent photoshoot for TIME France is now being viewed as an ...

Programme testing for BRCA mutation to resume next year after successful launch results, Health Secretary tells JC ...

Zydus Lifesciences has partnered with US-based Myriad Genetics to bring advanced cancer risk and prognostic tests to India, aiming to boost personalized oncology care.

Zydus partners with Myriad Genetics to introduce advanced cancer-risk assessment tests, enhancing precision diagnostics in India.

RAD51-based assessment effectively identifies HER2-negative metastatic breast cancer patients likely to respond to olaparib, especially with BRCA1/2 or PALB2 variants. RAD51-low tumors showed a higher ...

Cancer remains a major health burden in Kenya, accounting for about 7% of annual deaths, with an estimated 32,000 deaths and 44,000 new cases each year. The high mortality rate is largely due to late ...

Background The NHS Jewish BRCA Testing Programme is offering germline BRCA1 and BRCA2 genetic testing to people with ≥1 Jewish grandparent. Who have an increased likelihood of having an Ashkenazi ...

Last month, University College London Hospitals announced a new test for women at high risk of ovarian cancer due to inherited BRCA1 or BRCA2 gene mutations, who wish to defer preventative surgery. Dr ...

Quality of care (QoC) measures among patients with high-risk non–muscle-invasive bladder cancer (HR-NMIBC) who are unresponsive to bacillus Calmette-Guérin (BCG) treatment: A SEER-Medicare analysis.

Insurance covers some genetic tests, such as BRCA tests for breast cancer, if you meet certain requirements. Find Cheap Health Insurance Quotes in Your Area But there are about 70,000 different ...